======= OSR2 =======
== Gene Information ==
* **Official Symbol**: OSR2
* **Official Name**: odd-skipped related transciption factor 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=116039|116039]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q8N2R0|Q8N2R0]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=OSR2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20OSR2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/611297|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: N/A
|zf-C2H2|
|embryonic skeletal limb joint morphogenesis|
|limb joint morphogenesis|
|osteoblast proliferation|
|embryonic skeletal joint morphogenesis|
|eyelid development in camera-type eye|
|embryonic skeletal joint development|
|middle ear morphogenesis|
|embryonic hindlimb morphogenesis|
|embryonic forelimb morphogenesis|
|hindlimb morphogenesis|
|positive regulation of bone mineralization|
|forelimb morphogenesis|
|positive regulation of biomineralization|
|positive regulation of biomineral tissue development|
|embryonic digit morphogenesis|
|regulation of bone mineralization|
|chondrocyte differentiation|
|metanephros development|
|positive regulation of ossification|
|roof of mouth development|
|mesonephros development|
|regulation of biomineral tissue development|
|regulation of biomineralization|
|embryonic skeletal system morphogenesis|
|bone morphogenesis|
|ear morphogenesis|
|odontogenesis|
|embryonic appendage morphogenesis|
|embryonic limb morphogenesis|
|embryonic skeletal system development|
|appendage morphogenesis|
|limb morphogenesis|
|cartilage development|
|limb development|
|appendage development|
|positive regulation of epithelial cell proliferation|
|regulation of ossification|
|bone development|
|ear development|
|connective tissue development|
|skeletal system morphogenesis|
|sensory organ morphogenesis|
|kidney development|
|renal system development|
|embryonic organ morphogenesis|
|RNA polymerase II regulatory region sequence-specific DNA binding|
|camera-type eye development|
|urogenital system development|
|regulation of epithelial cell proliferation|
|eye development|
|visual system development|
|sensory system development|
|sequence-specific DNA binding|
|embryonic organ development|
|skeletal system development|
|sensory organ development|
|cell population proliferation|
|embryonic morphogenesis|
|chordate embryonic development|
|embryo development ending in birth or egg hatching|
|head development|
|negative regulation of transcription by RNA polymerase II|
|positive regulation of cell population proliferation|
|animal organ morphogenesis|
|embryo development|
|negative regulation of transcription, DNA-templated|
|positive regulation of transcription by RNA polymerase II|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of RNA metabolic process|
|positive regulation of developmental process|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|positive regulation of transcription, DNA-templated|
|negative regulation of biosynthetic process|
|DNA-binding transcription factor activity, RNA polymerase II-specific|
|regulation of cell population proliferation|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|negative regulation of gene expression|
|positive regulation of RNA metabolic process|
|positive regulation of multicellular organismal process|
|tissue development|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp102|Nifuroxazide 5μM R03 exp102]]|-1.98|
|[[:results:exp33|Rotenone 2μM R00 exp33]]|-1.95|
|[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|-1.7|
|[[:results:exp463|Caffeine 2600μM R08 exp463]]|1.83|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 16739
* **Expression level (log2 read counts)**: 3.33
{{:chemogenomics:nalm6 dist.png?nolink |}}